Michael E. Meyers

All filings by Michael E. Meyers on record concern Memory Pharmaceuticals Corp. Over a trading history stretching from 16 October 2006 to 1 January 2009, the count stands at 4 filings.

Purchases make up the whole of the open-market record (1 purchase, €16k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.

The latest filing, published on 5 January 2009, reports a transaction of €30k in Memory Pharmaceuticals Corp. The last insider purchase was made public on 18 October 2006, 7,311 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.